Labour sector needs bigger reform than the PM revealed.
India's gross domestic product grew by 7.4 per cent in the first three months (Apr-Jun) of this fiscal mainly due to a robust manufacturing sector which clocked 8 per cent growth.
A comprehensive solution involves a complete overhaul of our education and training model.
Nearly 490 million people of working age are outside the bounds of India's unemployment assessments. A decrease in the unemployment rate could signal economic growth, but could just as well mean that people have given up looking for work. A revealing excerpt from Tata Sons Chairman N Chandrasekaran and Tata Chief Economist Roopa Purushothaman's Bridgital Nation: Solving Technology's People Problem.
OXSIGHT, founded in 2016 to create wearable technology devices based on how the brain manages visual information, began conducting trials in India two years ago in partnership with leading eye hospitals and clinics.
'Now is the time for India to course correct and for the government also to course correct,' says businessman Mangesh Khatri.
The company, which has recently made a foray into the frozen food segment under ITC Master Chef brand targeting both retail and food services players, is also planning to expand its reach to over 30 cities in the retail segment and 100 cities in food services segment during the period. ITC will be the third major organised player in the frozen food segment after McCain, which is mainly in the vegetarian segment and Venky's, which is in non-vegetarian.
There is a process to be followed for EUL and pre-qualification of vaccines under which a company has to complete phase 3 trials and submit the whole data to the regulatory department of WHO which is examined by an expert advisory group," Swaminathan said.
India's exports are expected to touch $360 billion in the current fiscal from $312.35 billion in 2013-14, Federation of Indian Export Organisations (FIEO) said.
Defence Minister Manohar Parrikar says global aircraft makers will have to get approval from their own governments to transfer technology and build jets in India.
Bharat Biotech, Serum Institute, Zydus Cadila, Panacea Biotec, Indian Immunologicals, Mynvax and Biological E are among the domestic pharma firms working on the coronavirus vaccines in India.
From relying on Russia for its first satellite launch, India is fast becoming a global hub to launch satellites, says T E Narasimhan
ISRO has an opportunity to be the one-stop shop for satellite manufacturing, and Alpha Design is just the booster it needed.
The biggest worry is not the shrinking of the labour market, but the collapse of good jobs.
The NIH said results of two studies of blood serum from people who had received Covaxin suggest that the vaccine generates antibodies that effectively neutralise the B.1.1.7 (Alpha) and B.1.617 (Delta) variants of SARS-CoV-2, first identified in the United Kingdom and India, respectively.
The vaccine candidate -- 'Covaxin' -- is being indigenously developed by the Bharat Biotech in collaboration with the Indian Council of Medical Research (ICMR).
As the industrial era wanes, the network era looms, notes Ajit Balakrishnan.
The FPI holding in India's top 100 companies, which are part of the Nifty 100 index, declined to 24.23 per cent on average at the end of March this year, from a high of 27.5 per cent at the end of March 2021. This is the lowest FPI holdings in India's top listed companies in at least three years. A general sell-off by FPIs has weighed on stock prices and the benchmark S&P BSE Sensex is down 8.5 per cent, from its 52-week high made in October 2021. Most analysts expect FPI flows to remain weak in FY23 as well, given rising bond yields in the US and an expected earnings slowdown in India due to high inflation and commodity prices.
He noted that it would take a long time for turn around the current situation in India
Modi is also likely to launch the Co-WIN (COVID Vaccine Intelligence Network) App, a digital platform created for real-time monitoring of COVID-19 vaccine delivery and distribution.
'Allegations of Reliance benefitting by thousands of crores is a figment of imagination, promoted by vested interests'
If we are to realise the full potential of biologics' ability to improve people's health, it is essential to encourage public policy and support R&D.
'We don't expect any immediate impact on salaried jobs.'
'We spent considerable time re-skilling all the employees, and then we created a new focus called the 'One Infosys'.'
Or, what will the Indian policy process allow it to be, says Ajit Balakrishnan.
'Let us remember that Make in India for defence must not be our goal.' 'The goal is to have a strong military to help the nation protect its identity and assert its will.'
PSA Peugeot Citroen has no plans to re-enter India's car market any time soon
'BPCL has always been spoken about as a multinational company though it is State-run... this sets our work culture also apart.'
Leading two-wheeler maker Hero MotoCorp is going full throttle to launch a Harley-Davidson model with retro styling as it looks to enter a very profitable segment in the premium motorcycle space, according to a senior company official. The alliance between Hero and Harley-Davidson fructified last year after the iconic US two-wheeler maker announced discontinuation of sales and manufacturing operations in India, a decade after it started selling its premium bikes in the country. "There are two legs to the Harley tie up strategy. One of course is that we are the sales distributors for Harley bikes in India.
The Pune-based vaccine major has entered into a collaboration with the University of Oxford and AstraZeneca to manufacture the vaccine.
So vaccinate employees and families, staff at home, rickshaw drivers, milkmen, service providers, shopkeepers and street vendors, says Naushad Forbes.
India has been ranked as the most attractive investment destination in the world for the next three years.
'This is a tragedy that must be stopped.'
There are around 6,500 diamond manufacturers of which Palanpuri Jains operate a mere 6 per cent, or around 400 companies. But they stand out for being highly interlinked through blood ties.
According to medical practitioners, the treatment is especially useful in controlling disease among those who have not received the vaccine or got only one shot and also the high-risk contacts of a patient.
Whistle-blower Dinesh Thakur will speak on Made-in-India drugs at an event in Washington.
The R&D plan, focused on diseases affecting poor nations, is expected to be ready by 2008 and may benefit Indian drug firms and contract research organisations in a big way.
India had the third-largest number of people living with HIV in the world at the end of 2013 and accounts for about four out of 10 people living with HIV in the Asian region.
© 2026 Rediff.com - Investor Information - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances